Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR® Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings Supernus to Present at the 2017 J.P. Morgan Healthcare Conference Supernus Wins Appeal Case on Oxtellar XR® Supernus Receives Nasdaq Non-Compliance Notice Supernus Provides Business Update Supernus to Host a Business Update Call Supernus to Present at Three November Healthcare Conferences Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD Supernus Schedules Conference Call to Present Results of Phase IIb Clinical Trial of SPN-812 in Children with ADHD Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »